FDA inspection
Pine Pharmaceuticals, LLC: FDA inspection ending Sep 30, 2024
FDA inspection 1246936 · Official Action Indicated (OAI) · Tonawanda, NY
Key facts
| Inspection ID | 1246936 |
|---|---|
| Firm | Pine Pharmaceuticals, LLC |
| FEI number | 3010943533 |
| Address | 355 Riverwalk Pkwy |
| City | Tonawanda |
| State | NY |
| ZIP | 14150 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Sep 30, 2024 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data